WARPTECHNEWS · LAB
HomeAIBusinessTechArchive
WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

  • Home
  • Archivio
  • Editor's Brief
  • Cerca
  • Il tuo account
  • Newsletter tech/AI

Informazioni legali

  • Privacy Policy
  • Termini di servizio
  • Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Home
Storia in 13 fonti

Trump threatens tariffs on imported generic drugs

While the possibility of levies on branded pharmaceuticals have had a limited impact on drugmaker revenues, tariffs of up to 200% on copycat medicines could — depending on the specifics — prove more disruptive.

Raccontata dabiopharmadive.comsupplychaindive.comtimesofindia.indiatimes.comeconomictimes.indiatimes.comfrance24.combenzinga.comnewsbytesapp.comswissinfo.chhindustantimes.comindependent.co.ukasia.nikkei.comscmp.com+1 altre

Confronto fonti

6 prospettive sulla stessa storia
AI · summaries
biopharmadive.comStai leggendo23 h fa

Trump threatens tariffs on imported generic drugs

While the possibility of levies on branded pharmaceuticals have had a limited impact on drugmaker revenues, tariffs of up to 200% on copycat medicines could — depending on the specifics — prove more disruptive.

originale

Timeline cronologica

  1. mercoledì 22 luglio 2026·biopharmadive.com

    Trump threatens tariffs on imported generic drugs

    While the possibility of levies on branded pharmaceuticals have had a limited impact on drugmaker revenues, tariffs of up to 200% on copycat medicines could — depending on the…

  2. mercoledì 22 luglio 2026·supplychaindive.com

    Trump maps out 200% tariffs for generic pharmaceuticals

    The president said Tuesday he would maintain duty-free treatment for qualifying goods the next two years before hiking the tariffs in ensuing years.

cbsnews.com
3 h fa

Trump plans 100% tariffs on imported generic drugs. Here's what experts say.

Health policy experts say higher import duties could increase costs and strain supplies while offering no guarantee manufacturers will shift production to the U.S.

Leggi questa versione → originale
cnbc.com10 h fa

Trump's generic drug tariffs: What they could mean for medicine prices, manufacturers and supply

Trump's generic drug tariff plan raises questions over prices, U.S. manufacturing and which drugmakers stand to gain or lose as details remain unclear.

Leggi questa versione → originale
newsbytesapp.com19 h fa

Trump threatens tariff on generic medicines: Should India be worried?

US President Trump announced a two-year tariff exemption for imported generic medicines, warning of steep 200% duties if production doesn't shift to the US afterward.

Leggi questa versione → originale
economictimes.indiatimes.com16 h fa

Trump’s 100% generic drug duty threatens US low-cost supply

President Donald Trump has given generic drugmakers two years to shift manufacturing to the US or face 100% import tariffs from August 2028, rising to 200% a year later. The move threatens India's pharmaceutical…

Leggi questa versione → originale
cryptobriefing.com7 h fa

Trump proposes 100% tariffs on imported generic drugs starting 2028, with 200% penalties to follow

Trump announces 100% tariffs on imported generic drugs starting August 2028, escalating to 200% in 2029, aiming to reshore US pharmaceutical

Leggi questa versione → originale
  • mercoledì 22 luglio 2026·timesofindia.indiatimes.com

    Trump announces 0% tariff on generic medicines for two years; 200% thereafter

    US President Donald Trump on Tuesday announced a phased tariff regime on imported generic medicines, saying they will continue to enter the United States duty-free for two years…

  • mercoledì 22 luglio 2026·economictimes.indiatimes.com

    Trump announces new generic drugs tariff plan: No tariffs for 2 years, then 100%, and then 200%

    Trump ⁠has been pressuring drugmakers through his most-favored-nation drug ​pricing policy to lower prices to ​what people pay in other high-income countries.

  • mercoledì 22 luglio 2026·france24.com

    Trump announces 100% tariffs on imported generic pharmaceutical drugs

    US President Donald Trump announced a 100% tariff on imported generic pharmaceutical drugs on Tuesday. The tariff, which aims to bolster US pharmaceutical production, is set to go…

  • mercoledì 22 luglio 2026·benzinga.com

    Trump Sets August 1 Start for Generic Drug Tariff Clock, Warns of 200% Duties: Companies Must 'Build Plan

    Trump says imported generic drugs face 0% tariffs for 2 years, before 100% and then 200% duties.

  • mercoledì 22 luglio 2026·newsbytesapp.com

    Trump threatens tariff on generic medicines: Should India be worried?

    US President Trump announced a two-year tariff exemption for imported generic medicines, warning of steep 200% duties if production doesn't shift to the US afterward.

  • mercoledì 22 luglio 2026·swissinfo.ch

    Trump’s 100% Generic Drug Duty Threatens US Low-Cost Supply

    (Bloomberg) -- Generic drug manufacturers will have two years to move production to the US or face a 100% import duty from August 2028, President Donald Trump said, threatening…

  • mercoledì 22 luglio 2026·hindustantimes.com

    0, 100, 200: How Trump's latest generic medicines tariffs could affect India

    Indian drugmakers export around $9-10 billion worth of generic medicines to the American market every year. | India News

  • mercoledì 22 luglio 2026·economictimes.indiatimes.com

    Trump's 200% drug tariff plan: Is India's pharma industry about to face an economic storm?

    The United States is set to implement a phased approach to tariffs on generic drug imports, beginning at zero percent and escalating to one hundred percent, eventually reaching…

  • mercoledì 22 luglio 2026·economictimes.indiatimes.com

    Trump’s 100% generic drug duty threatens US low-cost supply

    President Donald Trump has given generic drugmakers two years to shift manufacturing to the US or face 100% import tariffs from August 2028, rising to 200% a year later. The move…

  • mercoledì 22 luglio 2026·economictimes.indiatimes.com

    200% Trump tariff shock? India’s cheap pills may still beat US rivals

    US President Donald Trump's proposed tariffs of up to 200% on imported generic medicines could put pressure on India's pharmaceutical exporters, but the country's cost advantage…

  • mercoledì 22 luglio 2026·economictimes.indiatimes.com

    Indian pharma firms may yet survive Trump's 200% tariff bombshell

    Donald Trump's proposed up to 200% tariff on generic drug imports has raised concerns for Indian pharma companies, but industry experts say the long-term impact may be limited.…

  • mercoledì 22 luglio 2026·economictimes.indiatimes.com

    Explained: What Donald Trump's up to 200% pharma tariffs mean for Indian investors

    Donald Trump's announcement of tariffs of up to 200% on pharmaceutical imports triggered a selloff in Indian pharma stocks. However, analysts believe the long-term impact could be…

  • mercoledì 22 luglio 2026·timesofindia.indiatimes.com

    Donald Trump’s 200% tariffs on pharma: Why India’s generic medicines could still remain competitive

    In a blow to India’s pharmaceutical industry, the Donald Trump administration has announced up to 200% tariffs on generic drugs that will be applicable in the coming years.

  • mercoledì 22 luglio 2026·independent.co.uk

    Trump announces plan for 200% tariffs on imported generic drugs

    Under the plan, announced on Truth Social, generic drugs imported into the U.S. would remain tariff-free for two years beginning Aug. 1

  • mercoledì 22 luglio 2026·asia.nikkei.com

    Trump's generic drugs tariff threatens Indian pharma's top market

    100% levy from 2028 could accelerate push into higher value medicines

  • mercoledì 22 luglio 2026·scmp.com

    What would 200% US tariffs on generic drugs mean for China’s pharmaceutical industry?

    Analysts say that China’s pivot from generics to innovative drugs means the industry is less exposed to US levies.

  • mercoledì 22 luglio 2026·cnbc.com

    Trump's generic drug tariffs: What they could mean for medicine prices, manufacturers and supply

    Trump's generic drug tariff plan raises questions over prices, U.S. manufacturing and which drugmakers stand to gain or lose as details remain unclear.

  • mercoledì 22 luglio 2026·timesofindia.indiatimes.com

    US tariffs could raise drug prices, squeeze Indian generics

    NEW DELHI: India's $30-billion pharma industry is staring at a fresh challenge after US President Donald Trump announced that generic medicines imported into the US would face…